Labiana Health S.A.
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms,… Read more
Labiana Health S.A. (LAB) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2022: 0.604x
Based on the latest financial reports, Labiana Health S.A. (LAB) has a cash flow conversion efficiency ratio of 0.604x as of December 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€4.68 Million) by net assets (€7.74 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Labiana Health S.A. - Cash Flow Conversion Efficiency Trend (2022–2022)
This chart illustrates how Labiana Health S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Labiana Health S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Labiana Health S.A. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Goldspot Discoveries Corp
OTCQX:SPOFF
|
-0.005x |
|
GFM Services Bhd
KLSE:0039
|
0.033x |
|
LITIUM AB SK1
F:5TW
|
N/A |
|
Opus One Resources Inc
V:OOR
|
0.000x |
|
Legacy Minerals Holdings Ltd
AU:LGM
|
-0.075x |
|
BROADPEAK S.A. EO -02
F:J73
|
N/A |
|
Jooyontech
KO:044380
|
0.014x |
|
STXYF
PINK:STXYF
|
0.081x |
Annual Cash Flow Conversion Efficiency for Labiana Health S.A. (2022–2022)
The table below shows the annual cash flow conversion efficiency of Labiana Health S.A. from 2022 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | €7.74 Million | €4.68 Million | 0.604x | -- |